Vittorio Stefoni, MD

Ematologia "L. & A. Seragnoli" - Policlinico S. Orsola Malpighi

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

NIH RePORTER

Trial papers

PubMed author-name match

Trials

Studies that name Vittorio Stefoni, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:45 UTC. Open this list on ClinicalTrials.gov

Ph2
NCT02499627 · Bendamustine Plus Brentuximab Vedotin in HL and CD30+ PTCL in First Salvage Setting
Fondazione Italiana Linfomi - ETS · terminated · Lymphatic Diseases · principal investigator
Ph2
NCT02497131 · Study on the Role of Brentuximab Vedotin as Single Agent in the Treatment of Relapsed/Refractory CD30+ PTCL Patients
Fondazione Italiana Linfomi - ETS · completed · Lymphatic Diseases · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 06:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

PubMed returned no clinical-trial papers for this author name.